FREEMAN MASON (EVP Clinical Development) sold 0.2% of their position (6.00 shares) of CINCOR PHARMA, INC. on the open market
Open‑market sale worth $91.26 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−6.00
Price / share
$15.21
Trade value
$91.26
% of position
Common Stock
Shares
−2.49K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−40K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−100.00
Price / share
—
Trade value
—
% of position
Net shares
−42.60K
Net value
-$91.26
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2022 | S · Sale | −6.00 | $15.21 | $91.26 | 0.2% | 2.50K | 2.49K |
| Common Stock Direct | 2/24/2023 | U · U | −2.49K | — | — | 5.9% | 42.49K | 40K |
| Common Stock Direct | 2/24/2023 | D · Disposition | −40K | — | — | New position | 40K | 0.00 |
| Common Stock Indirect | 2/24/2023 | U · U | −100.00 | — | — | New position | 100.00 | 0.00 |
| Total | −42.60K | -$91.26 | ||||||
Stock Option (Right to Buy)
Common Stock
30.18K shares
Shares
−30.18K
Strike price
0.92
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
145.30K shares
Shares
−145.30K
Strike price
5.82
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
120.38K shares
Shares
−120.38K
Strike price
7.62
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock30.18K shares | 2/24/2023 | D · Disposition | −30.18K | 0.92 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock145.30K shares | 2/24/2023 | D · Disposition | −145.30K | 5.82 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock120.38K shares | 2/24/2023 | D · Disposition | −120.38K | 7.62 | — | 0.00 |